DIA
PAHC icon

Dean Investment Associates’s Phibro Animal Health PAHC Stock Holding History

Dean Investment Associates’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-134,304
Closed -$1.84M – 218
2023
Q2 		$1.84M Sell
134,304
-38,777
-22% -$556K 0.3% 121
2023
Q1 		$2.65M Buy
+173,081
New +$2.64M 0.42% 93

Other funds holding PAHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Dean Investment Associates's PAHC Position: Q3 2023 in Review

Dean Investment Associates sold out of Phibro Animal Health (PAHC) in Q3 2023, closing a stake of 134,304 shares — an estimated $1.84M sold.

Dean Investment Associates first reported a position in PAHC in Q1 2023 and held it in 2 quarters. The position peaked at $2.65M in Q1 2023. 125 funds tracked by Wall St. Rank hold PAHC as of Q3 2023.

  • Dean Investment Associates reported no remaining Phibro Animal Health position as of Q3 2023 after selling out during the quarter.
  • Dean Investment Associates sold 134,304 Phibro Animal Health shares in Q3 2023, an estimated $1.84M.
  • Dean Investment Associates first reported a position in Phibro Animal Health in Q1 2023 and held it in 2 quarters.
  • Dean Investment Associates's Phibro Animal Health position peaked at $2.65M in Q1 2023.
  • 125 funds tracked by Wall St. Rank held Phibro Animal Health as of Q3 2023.

Based on Dean Investment Associates's 13F filing for Q3 2023, filed 13 Nov 2023.